Parkinson's disease trials recruiting in Connecticut

All Parkinson's disease trials nationally

Cities in Connecticut

Recruiting trials in Connecticut

• A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
  NCT06565195 · Phase: Phase 1 · Ages: 30 Years to 80 Years · Sex: All (male and female) · Connecticut: New Haven
• A Comparative Performance Study Between High and Standard Resolution Positron Emission Tomography Camera Using [18F] AV-133 in Prodromal Parkinson's Disease
  NCT07809438 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: New Haven
• A Study of Buntanetap in Participants With PD
  NCT07284784 · Phase: Phase 2, Phase 3 · Ages: 40 Years to 85 Years · Sex: All (male and female) · Connecticut: Stamford
• A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
  NCT06976268 · Phase: Phase 2, Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Connecticut: Farmington, New Haven
• A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
  NCT07174310 · Phase: Phase 3 · Ages: 50 Years to 85 Years · Sex: All (male and female) · Connecticut: New Haven
• A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
  NCT07804615 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Connecticut: Stamford
• A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
  NCT07330258 · Phase: Not specified · Ages: 45 Years to 75 Years · Sex: All (male and female) · Connecticut: New Haven
• Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder
  NCT07217054 · Phase: Not specified · Ages: 40 Years to 99 Years · Sex: All (male and female) · Connecticut: Branford
• Daily Amino Acid Supplementation for People With Parkinson's Disease
  NCT07115563 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 90 Years · Sex: All (male and female) · Connecticut: Farmington, Storrs
• Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging)
  NCT07265596 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: New Haven
• Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease
  NCT07020026 · Phase: Phase 2 · Ages: 45 Years to 85 Years · Sex: All (male and female) · Connecticut: New Haven
• Evaluation of the Pharmacokinetics, Biodistribution and Radiation Dosimetry of [18F]MODAG-009 Positron Emission Tomography (PET) Radiotracers in Adult Healthy Volunteers
  NCT07617688 · Phase: Early Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · Connecticut: New Haven
• Imaging Depression in Parkinson's Disease
  NCT06402955 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Connecticut: New Haven
• PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
  NCT04477785 · Phase: Not specified · Ages: 30 Years and older · Sex: All (male and female) · Connecticut: New Haven
• Parkinson's Foundation PD GENEration Genetic Registry
  NCT04994015 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: Farmington, Hartford
• Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503
  NCT06303921 · Phase: Early Phase 1 · Ages: 40 Years to 85 Years · Sex: All (male and female) · Connecticut: New Haven
• The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
  NCT07610369 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Connecticut: New Haven